Castration Resistant Metastatic Prostate Cancer

Oncology

Prevalence

256.0 / 100K

Incidence

111.0 / 100K/yr

4 drugs in development·2 companies·1 clinical trial

Drug Pipeline by Phase

Compare drugs

Testosterone cypionate vs Testosterone enanthateTestosterone cypionate vs [225ac]ac-aky-2519Testosterone cypionate vs [64cu]cu-aky-2519

Frequently asked questions

How many drugs are in development for Castration Resistant Metastatic Prostate Cancer?

BioSniper tracks 4 drugs in development for Castration Resistant Metastatic Prostate Cancer across 2 companies.

How many clinical trials target Castration Resistant Metastatic Prostate Cancer?

There are 1 clinical trial targeting Castration Resistant Metastatic Prostate Cancer tracked by BioSniper.

What is the prevalence of Castration Resistant Metastatic Prostate Cancer?

The estimated prevalence of Castration Resistant Metastatic Prostate Cancer is approximately 256.0 per 100,000 population.

Deep-dive into Castration Resistant Metastatic Prostate Cancer

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Castration Resistant Metastatic Prostate Cancer — Drugs in Development & Clinical Trials | BioSniper